Skip to content
411 PRESS
WarningRecall #D-0690-2026Drug / Pharmaceutical

CareFusion 213 Recalls BD ChloraPrep Clear

CareFusion 213, LLC · Class II — Moderate Risk

Assorted pharmaceutical pills and tablets — representative photo for FDA drug recall
An assortment of pharmaceutical pills (representative file photo). Specific recalled product: see recall details below. Photo: Michael Nutt / Wikimedia Commons (CC BY-SA 2.0).

Product Description

BD ChloraPrep Clear, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol), 60 x 1 mL applicators/carton, 0.03fl oz (1 mL) each, STERILE SOLUTION, CareFusion 123, LLC, El Paso, TX, subsidiary of Beckton, Dickson and Co. NDC 54365-400-31

Reason for Recall

Lack of Assurance of Sterility: Affected product may exhibit an open or incomplete seal on the packaging of the applicator

FDA Classification

Class II — Moderate Risk

A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

Distribution

U.S.A. Nationwide

Remedy

Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.

411 Press Analysis

A Class II FDA recall has been issued for a pharmaceutical product from CareFusion 213, LLC, initiated on July 9, 2026. Lack of Assurance of Sterility: Affected product may exhibit an open or incomplete seal on the packaging of the applicator. This recall covers 43,066,599 units, distributed in U.S.A. Nationwide. While not the highest severity, consumers should exercise caution and stop using the product until the recall is resolved.

Independent news on labor, safety, and accountability.